Alpha Cognition appoints Bethany Sensenig to board of directors

Alpha Cognition Inc.

Bethany Sensenig appointed director on April 15, 2026; previously CFO/Head of Ops at Radius Health.
Sensenig also serves on boards of Supernus Pharmaceuticals (SUPN) and KalVista Pharmaceuticals (KALV).
Received initial grant of 5,489 RSUs and 6,991 stock options (exercise price $6.65), vesting one year from grant.
Sensenig spent 13 years at Biogen in senior finance roles with P&L accountability for over $1B annual revenue.
Compensated per company's non-employee director compensation policy; no arrangements or family relationships.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.